Check out the companies making headlines in midday trading: Apple — Shares rebounded more than 5% on Wednesday after several days of selling pressure on the iPhone maker. Apple manufactures much of its products in China, which has been a key worry for investors in recent days in light of President Donald Trump's 104% tariff on Beijing that took effect on Wednesday. Walmart — The retail stock gained 5% after Chief Financial Officer John Rainey said in an investor presentation that Walmart emerges with greater share when it leans into periods of economic uncertainty. The company scrapped its first-quarter operating guidance but left its full-year guidance unchanged. Capri — Shares rallied more than 10.3% after The Wall Street Journal reported that a deal for Capri to sell Versace to Prada is at risk of collapsing. Delta Air Lines — Shares popped more than 7% even after the company pulled its 2025 forecast and CEO Ed Bastian said tariffs are hurting bookings . Trump Media & Technology Group — Shares of President Trump's social media company advanced 8%. Earlier on Wednesday, Trump said in a Truth Social post that "THIS IS A GREAT TIME TO BUY!!! DJT." Citigroup , Wells Fargo , JPMorgan Chase — Bank stocks broadly declined during another volatile day in financial markets as worries about a possible recession persisted. Shares of Citigroup and Wells Fargo fell more than 3% each. JPMorgan Chase dipped 0.6%. Tesla — Elon Musk's electric vehicle company climbed more than 5%, recovering some of its recent steep losses. The stock is down more than 17% over the past week amid rising trade tensions with China and major U.S. trading partners. Eli Lilly, Pfizer , AbbVie — Shares of key pharmaceutical giants tumbled after President Trump said Tuesday evening that the U.S. is going to announce " very shortly a major tariff on pharmaceuticals ." AbbVie and Eli Lilly shares both dropped more than 4%, while Pfizer fell 3%. — CNBC's Jesse Pound, Michelle Fox, Yun Li and Sean Conlon contributed reporting. Get Your Ticket to Pro LIVE Join us at the New York Stock Exchange! Uncertain markets? Gain an edge with CNBC Pro LIVE , an exclusive, inaugural event at the historic New York Stock Exchange. In today's dynamic financial landscape, access to expert insights is paramount. As a CNBC Pro subscriber, we invite you to join us for our first exclusive, in-person CNBC Pro LIVE event at the iconic NYSE on Thursday, June 12. Join interactive Pro clinics led by our Pros Carter Worth, Dan Niles and Dan Ives, with a special edition of Pro Talks with Tom Lee. You'll also get the opportunity to network with CNBC experts, talent and other Pro subscribers during an exciting cocktail hour on the legendary trading floor. Tickets are limited!
Stocks making the biggest moves midday: Apple, Tesla, AbbVie, Delta Air Lines and more
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...